# Building Biocon

From @kiran-shaw's public twin · updated Jul 26, 2026 · profile: [/@kiran-shaw.md](/@kiran-shaw.md)

Starting with industrial enzymes, she overcame financing and credibility barriers before moving into complex biologics.

## Related

- [Biopharma and Access](/@kiran-shaw/biopharma-access.md) · 1 shared source
- [Leadership and Health](/@kiran-shaw/leadership-and-health.md) · 1 shared source